|Day Low/High||6.01 / 6.33|
|52 Wk Low/High||4.62 / 16.41|
Upside - +135% (Hoth Therapeutics mRNA Frame-Shifting Therapeutic, HT-KIT, proves effective against aggressive cancer cells) - +30% (confirms to be acquired by Thoma Bravo for $65.25/shr in cash valued at $6.9B) - +29% (Novel COVID-19 drug candidate...
Right now, there is tension between overbought technical conditions and an appetite for speculative trading.
Sure, we've got inflation and low consumer sentiment, but what works for me is trading the action that is in front of my face.
The stock picking is spreading to some of the small-cap values.
Pockets of momentum are narrow Tuesday as rotation continues.
The question now is whether the lows that were hit on Wednesday morning will serve as short-term support as we move into earnings season.
There's good follow-through buying Thursday, but another good close is needed to restore confidence in an uptrend.
Traders are doing what they do when there's volatility.
There was over $2 million in insider buying earlier in the year so management appears to be optimistic.
My positions change very fast and I'm actively trading all these names.
The process of closing the gap between large-caps and secondary stocks may be starting today.
We are heading into some poor seasonality next week and I plan to move incrementally.
The key is to move incrementally as we head into the seasonally best time of the year.
Speculative trading has perked up again, and traders are looking hard for big movers.